recommendations for HF patients with reduced LVEF (HFrEF) are deliberative because of the limited data. Recently, the CASTLE-AF study showed that RF-based catheter ablation for AF in patients with reduced LVEF was associated with lower rates of all-cause mortality and hospitalization for worsening HF. 5 Point-by-point ablation by RF often results in a favorable clinical outcome, but its complexity demands a long learning curve and relatively long procedural duration. In this context the 2nd-generation cryoballoon (CB2, Arctic Front Advance, Medtronic Inc., A trial fibrillation (AF) and heart failure (HF) often coexist and AF increases the risk of hospitalization because of decompensated HF in those patients. 1-3 Pulmonary vein isolation (PVI) is the cornerstone of invasive AF treatment. Radiofrequency (RF)-based catheter ablation for HF patients, compared with amiodarone therapy, significantly reduces recurrent AF and improves left ventricular ejection fraction (LVEF) in selected cases. 4 Although current guidelines recommend ablation therapy to maintain sinus rhythm (SR) for symptomatic AF patients,